<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
EXEL
Exelixis
$
()


  • Exelixis treatment of pancreatic neuroendocrine tumors granted orphan status

    6/5/2024 - 14:57pm
  • Fly Intel: Pre-market Movers

    5/20/2024 - 08:55am
  • Exelixis announcess settlement of cabozantinib patent litigation with Cipla

    5/20/2024 - 08:21am
  • Exelixis initiated with neutral view at Stephens, here's why

    5/13/2024 - 16:32pm
  • Exelixis price target raised by $2 at TD Cowen, here's why

    5/1/2024 - 07:37am
  • Fly Intel: After-Hours Movers

    4/30/2024 - 18:43pm
  • Exelixis reports Q1 EPS 17c, consensus 24c

    4/30/2024 - 16:07pm
  • Exelixis just downgraded at Barclays, here's why

    4/11/2024 - 04:42am
  • Biotech Alert: Searches spiking for these stocks today

    3/11/2024 - 11:13am
  • Exelixis exec Haley sells 47,020 common shares

    2/27/2024 - 19:01pm
  • Fly Insider: Exelixis, Akami among week's notable insider trades

    2/26/2024 - 15:11pm
  • Biotech Alert: Searches spiking for these stocks today

    2/9/2024 - 11:12am
  • Exelixis backs FY24 revenue view $1.825B-$1.925B, consensus $1.91B

    2/6/2024 - 16:18pm
  • Exelixis reports Q4 adjusted EPS 33c, consensus 21c

    2/6/2024 - 16:17pm
  • Cybrexa regains rights to CBX-12

    2/6/2024 - 08:12am
dynamic_feed Breaking News